Medicine and Dentistry
Implantable Automatic Defibrillator
100%
Hypertrophic Cardiomyopathy
88%
Sudden Cardiac Death
82%
Commotio Cordis
80%
Sudden Death
73%
Defibrillator
72%
Ventricular Fibrillation
69%
Athletes
61%
Resuscitation
52%
Ventricular Tachycardia
48%
Heart Failure
46%
Cardiovascular System
43%
Heart Ventricle Arrhythmia
41%
Atrial Fibrillation
40%
Heart Arrest
37%
Cardiac Dysrhythmia
35%
Thoracic Wall
30%
Faintness
26%
Defibrillation
24%
Shock (Circulatory)
23%
Arrhythmogenic Right Ventricular Dysplasia
20%
Electrocardiogram
18%
Disease
17%
Out of Hospital Cardiac Arrest
15%
Symptom
14%
Catheter Ablation
14%
Risk Stratification
14%
Catheter Ablation
13%
Drug Therapy
12%
Cardiomyopathy
12%
Exercise
12%
Prevalence
11%
Public Access Defibrillation
11%
Heart Disease
11%
Tachyarrhythmia
11%
Primary Prevention
11%
Myocardial Infarction
11%
Paroxysmal Atrial Fibrillation
10%
Dilated Cardiomyopathy
9%
Heart Ventricle Flutter
9%
Cohort Effect
9%
Physical Activity
8%
Cardiovascular Disease
8%
Cardiac Resynchronization Therapy
8%
Dysplasia
8%
Antiarrhythmic Agent
8%
Secondary Prevention
8%
Arrhythmia
8%
Repolarization
8%
Clinical Trial
8%
Keyphrases
Sudden Cardiac Death
40%
Ventricular Arrhythmia
37%
Commotio Cordis
34%
Hypertrophic Cardiomyopathy
33%
Sudden Death
31%
Implantable Defibrillator
28%
Ventricular Fibrillation
23%
Arrhythmia
23%
Clinical Practice Guidelines
23%
Joint Committees
22%
Atrial Fibrillation
18%
Cardiopulmonary Resuscitation
16%
Blowing
15%
Heart Failure Management
14%
Syncope
14%
Executive Summary
13%
Heart Failure
13%
Cardiac Arrest
13%
Chest Wall
13%
Automated External Defibrillator
11%
College Athletics
11%
High School Athletics
11%
Athletics Programmes
11%
Wall Impact
10%
Consensus Statement
9%
Supraventricular Tachycardia
9%
Out-of-hospital Cardiac Arrest
9%
Focused Update
9%
American Heart Association Guidelines
9%
Baseball
9%
Emergency Management
8%
Emergency Preparedness
8%
Association Task
8%
Emergency Cardiovascular Care
8%
Advanced Cardiovascular Life Support
8%
Clinical Trials
8%
High Risk
8%
Hazard Ratio
7%
Young Athletes
7%
Patients with Heart Failure
7%
Structural Heart Disease
7%
Arrhythmogenic Right Ventricular Dysplasia
7%
Heart Failure Guidelines
6%
Scientific Statement
6%
AHA Guidelines
6%
Arrhythmogenic Cardiomyopathy
6%
Clinical Outcomes
6%
Cardiac Resynchronization Therapy
6%
Life-threatening
6%
Defibrillator
6%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Ventricle Arrhythmia
55%
Heart Arrhythmia
53%
Atrial Fibrillation
50%
Hypertrophic Cardiomyopathy
49%
Commotio Cordis
42%
Heart Ventricle Fibrillation
39%
Heart Ventricle Tachycardia
35%
Sudden Cardiac Death
31%
Sudden Death
30%
Heart Failure
28%
Disease
21%
Cardiomyopathy
15%
Heart Infarction
15%
Cardiovascular Disease
14%
Heart Disease
14%
Heart Right Ventricle Dysplasia
13%
Antiarrhythmic Agent
13%
Heart Arrest
12%
Prevalence
9%
Cardiovascular Malformation
8%
Faintness
7%
Symptom
7%
Coronary Artery Disease
7%
Clinical Trial
7%
Monomorphic Ventricular Tachycardia
6%
Acute Heart Infarction
6%
Torsade Des Pointes
6%
Epileptic Absence
6%
Heart Atrium Arrhythmia
6%
Placebo
6%
Sotalol
5%
Pharmacotherapy
5%
Risk Evaluation
5%
Congestive Cardiomyopathy
5%
Paroxysmal Atrial Fibrillation
5%
Population Study
5%
